Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

Zydus Lifesciences is innovating a single-device for semaglutide. This device can deliver multiple strengths of the drug. It ...

The general anesthesia drugs market plays a crucial role in modern surgical practices, enabling safe and pain-free procedures for patients undergoing various operations. General anesthesia drugs are ...

In this video interview, Michel van Harten, MD, CEO, myTomorrows, highlights how artificial intelligence can be used to address logistical barriers such as access and treatment cost.

Urologist Dr. Jamin Brahmbhatt knows the complexities surrounding prostate-specific antigen testing with his patients. Here’s ...

Shares of Hinge Health jumped 22% above the initial public offering price in the company's New York Stock Exchange debut on ...

While cohort A met the primary endpoint among other endpoints in the Phase II trial, cohort B failed to meet its primary ...

The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...